Dylan is a co-founder of Jacaranda Biosciences, Inc.  He holds a BS from Yale, MD from Weill-Cornell Medical College, and PhD in sensory neuroscience from the Rockefeller University, and completed residency and fellowship at Stanford School of Medicine and Seattle Children's Hospital, respectively.  He is a clinician-scientist, Director of the Children's Communication Center, and Associate Professor in the Department of Otolaryngology-Head and Neck Surgery at the University of California, San Francisco. In addition to being an active, practicing pediatric otologic surgeon, his research is centered on discovering fundamentally better ways to help people hear, from understanding and addressing disparities in hearing health care, identifying new genetic causes for deafness, and developing new treatment for hearing loss. Together with co-founder Elliott Sherr, Dylan's lab made the foundational discovery that the Unfolded Protein Response is critically involved in both genetic and acquired hearing loss, and that this pathway can be targeted to treat hearing loss.